In this press conference called "Artificial Intelligence to Help ECG", experts from the field of cardiovascular disease and electrocardiogram, doctors in primary hospitals, medical and financial journalists, and partners are paying attention to this application in artificial intelligence medical system for automatic analysis and diagnosis of cardiac electrocardiogram.

      In the domestic market, AI-ECG Platform is expected to gain rapid promotion through the help of online and offline operation channels, and further promotes the synergy of the company's various business segments. In the international aspect, medical machinery based on the AI-ECG Platform ECG automatic analysis and diagnosis system has been registered by the US Food and Drug Administration (FDA) and has passed the RTA review. It is expected that it will soon be internationally get practical application in 2018.